Description
BSE announces listing and trading admission of 1,023,195 new equity shares issued under ESOP/ESOS by 10 companies, effective October 21, 2025.
Summary
BSE has announced the listing and admission to trading of further securities issued by 10 companies under their Employee Stock Option Plans (ESOP) and Employee Stock Option Schemes (ESOS). A total of 1,023,195 new equity shares will be listed and available for trading effective Tuesday, October 21, 2025. None of the shares are under lock-in period.
Key Points
- Total of 10 companies issuing new shares under ESOP/ESOS schemes
- Combined total of 1,023,195 new equity shares to be listed
- Effective date for trading: October 21, 2025
- No lock-in period applicable to any of the shares
- Face values range from Re. 1 to Rs. 10 depending on the company
- Notice issued by Kinnar Mehta, Assistant Vice President, BSE
Company-Wise Breakdown
| Company | Scrip Code | Shares | Face Value | ISIN |
|---|---|---|---|---|
| AU Small Finance Bank Limited | 540611 | 160,556 | 10 | INE949L01017 |
| AXIS Bank Ltd. | 532215 | 26,763 | 2 | INE238A01034 |
| Gokaldas Exports Ltd | 532630 | 11,500 | 5 | INE887G01027 |
| ICICI Bank Ltd. | 532174 | 125,223 | 2 | INE090A01021 |
| IIFL Finance Limited | 532636 | 111,433 | 2 | INE530B01024 |
| Jagsonpal Pharmaceuticals Limited | 507789 | 93,445 | 2 | INE048B01035 |
| Onward Technologies Ltd. | 517536 | 6,500 | 10 | INE229A01017 |
| Poly Medicure Ltd | 531768 | 33,775 | 5 | INE205C01021 |
| Renaissance Global Limited | 532923 | 25,000 | 2 | INE722H01024 |
| Sai Life Sciences Limited | 544306 | 429,000 | 1 | INE570L01029 |
Regulatory Changes
No regulatory changes introduced. This is a routine listing notification for shares issued under existing ESOP/ESOS frameworks.
Compliance Requirements
- Trading members are informed to note the new securities for trading purposes
- Companies have completed their listing formalities with BSE
- All shares meet BSE listing requirements with no lock-in restrictions
Important Dates
- Notice Date: October 20, 2025
- Effective Trading Date: October 21, 2025 (Tuesday)
- Lock-in Expiry: Not Applicable (NA) - no lock-in period for any shares
Impact Assessment
Market Impact: Low - The issuance represents routine ESOP/ESOS share listings with relatively small quantities compared to the existing equity base of most companies. The largest single issuance is 429,000 shares by Sai Life Sciences Limited.
Liquidity Impact: Minimal incremental impact on float for most companies. Banking sector companies (AXIS Bank, ICICI Bank, AU Small Finance Bank) show larger absolute numbers but these represent a fraction of their existing share capital.
Dilution Impact: Negligible dilution for existing shareholders given the small proportion of new shares relative to existing equity base.
Investor Consideration: These shares are freely tradable from day one with no lock-in restrictions, allowing employee option holders to liquidate positions immediately if desired.
Impact Justification
Routine listing of ESOP/ESOS shares with minimal market impact; relatively small share quantities compared to existing float for most companies